Advertisement

Langenbeck's Archives of Surgery

, Volume 393, Issue 4, pp 521–526 | Cite as

Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter

  • Kazuaki Shimada
  • Yoshihiro Sakamoto
  • Minoru Esaki
  • Tomoo Kosuge
Original Article

Abstract

Background

A curative hepatectomy is the mainstay of effective treatment for small hepatocellular carcinoma (HCC), but the treatment of large HCC remains challenging.

Materials and methods

The possible prognostic factors were retrospectively analyzed in 85 patients with large HCC (≥10.0 cm) who all underwent a hepatectomy for HCC between 1988 and 2004. A survival analysis was made by classifying the tumors into four spreading patterns according to the number of tumors and the presence of macroscopic tumor thrombus.

Results

A positive hepatitis B antigen, the earlier period of hepatectomy, a non-curative hepatectomy, multiple tumors, and portal vein invasion were identified as independent predictors of a poor prognosis. The median survival term and 5-year survival rate of patients with a solitary large HCC without a macroscopic tumor thrombus was 9.8 years and 69.8%, respectively. The tumor spreading patterns according to the number of tumors and the presence of a macroscopic tumor thrombus were statistically associated with a non-curative hepatectomy (p < 0.001). There was a statistical difference among 33 patients with large HCC undergoing a non-curative hepatectomy based on the presence of a macroscopic portal vein invasion (p = 0.0089).

Conclusion

A hepatectomy could yield an excellent long-term survival in patients with a solitary large HCC without a macroscopic tumor thrombus. Even if a curative hepatectomy could not be achieved, a hepatectomy might provide better survival in large HCC patients without a macroscopic tumor thrombus compared in those with macroscopic tumor thrombus.

Keywords

Large hepatocellular carcinoma Non-curative hepatectomy Multiple hepatocellular carcinoma Macroscopic tumor thrombus 

Notes

Acknowledgments

This study was supported by a Grant-in-Aid for cancer research from the Ministry of Health, Welfare and Labor of Japan.

References

  1. 1.
    Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382PubMedCrossRefGoogle Scholar
  2. 2.
    Lau WY, Leung TWT, Yu SCH, Ho SKW (2003) Percutaneous local ablative therapy for hepatocellular carcinoma. A review and look into the future. Ann Surg 237:171–179PubMedCrossRefGoogle Scholar
  3. 3.
    Mazzaferro V, Regalia E, Doci R, Castaing D, Diamond T, Dennison A (1996) N Engl J Med 334:693–699PubMedCrossRefGoogle Scholar
  4. 4.
    Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469PubMedCrossRefGoogle Scholar
  5. 5.
    Poon RT, Fun ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592–602PubMedCrossRefGoogle Scholar
  6. 6.
    Hanazaki K, Kajikawa S, Shimozawa N et al (2002) Hepatic resection for hepatocellular carcinoma in diameter of ≥10 cm. Hepatogastroenterology 49:518–523PubMedGoogle Scholar
  7. 7.
    Yeh CN, Lee WC, Chen MF (2003) Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 10:1070–1076PubMedCrossRefGoogle Scholar
  8. 8.
    Nagano Y, Tanaka K, Togo S et al (2005) Efficacy of hepatic resection for hepatocellular carcinoma larger than 10 cm. World J Surg 29:66–71PubMedCrossRefGoogle Scholar
  9. 9.
    Liau KH, Ruo L, Shia J et al (2005) Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 104:1948–1955PubMedCrossRefGoogle Scholar
  10. 10.
    Ikai I, Yamaoka Y, Yamamoto Y et al (1998) Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastases. Proposal as a standard therapy. Ann Surg 277:433–439CrossRefGoogle Scholar
  11. 11.
    Liver Cancer Study Group of Japan (1997) Classification of primary liver cancer (English edition). Kanehara & Co, Ltd, TokyoGoogle Scholar
  12. 12.
    O’Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperative hepatocellular carcinoma. Br J Surg 90:325–331PubMedCrossRefGoogle Scholar
  13. 13.
    Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection. An analysis of 610 patients over 16 years old. Ann Surg 244:265–273PubMedCrossRefGoogle Scholar
  14. 14.
    Matsui O, Kadoya M, Yoshikawa J et al (2003) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83Google Scholar
  15. 15.
    Shiratori Y, Shiina S, Imamura M et al (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22:1027–1033PubMedCrossRefGoogle Scholar
  16. 16.
    Shirabe K, Shimada M, Kajiyama K et al (1998) Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 83:2312–2316PubMedCrossRefGoogle Scholar
  17. 17.
    Wu CC, Ho YZ, Ho WL et al (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82:122–126PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Kazuaki Shimada
    • 1
  • Yoshihiro Sakamoto
    • 1
  • Minoru Esaki
    • 1
  • Tomoo Kosuge
    • 1
  1. 1.Department of Hepatobiliary and Pancreatic Surgery DivisionNational Cancer Center Central HospitalChuo-kuJapan

Personalised recommendations